Members of the 27 eTRANSAFE Consortium partners gathered for two days in Barcelona to review the progress of the project done in the past months. eTRANSAFE aims to develop predictive services, contributing to the safety assessment of chemical compounds. Integrative analysis of preclinical and clinical data for generation of candidate translational biomarkers is another important goal of the project.
Francois Pognan (Novartis) and Carlos Díaz (Synapse) gave an overall vision and management of the project, followed by Eva Molero`s (Synapse) talk on the need to consider sustainability implications of any decision made in the project from the very start. The two day meeting was organised around 4 workshops: 1) Text mining of toxicology reports (Laura Furlong), 2) Data Workshop (Carlos Díaz and Thomas Steger-Hartmann), focused on data identification and the development of automated extraction & transfer procedures, 3) System workshop (François Pognan and Ferran Sanz) addressed the software sustainability and its technical considerations and 4) Biomarkers (Bob van de Water), focused on the collaboration of TransQST and eTRANSAFE in WP7.
The outcome of the workshops was an overall agreement on several important issues such as the process for the collection of preclinical and clinical data, the strategy for text mining of toxicological reports and a revised roadmap for biomarker approach.
The eTRANSAFE project was launched on September 1st, 2017 and has been sponsored by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking.
For more information contact firstname.lastname@example.org or check out http://etransafe.eu/.